Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.
Diabeloop
Venture Round in 2024
Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.
Unseenlabs
Series C in 2024
Unseenlabs is a French company founded in 2015 and headquartered in Rennes, Brittany, specializing in marine surveillance services. The company designs and develops advanced spectrum surveillance payloads that enable the detection and tracking of non-cooperative vessels worldwide. Unseenlabs offers comprehensive solutions that encompass satellite design, deployment, and operational support. By launching satellites that can detect and geolocate signals and electromagnetic waves emitted by ships, Unseenlabs provides clients with the capability to monitor maritime activities, even when vessels disable their Automatic Identification System beacons. This technology is particularly valuable for identifying illegal operations such as fishing violations, degassing, and maritime piracy.
Vulkam
Venture Round in 2023
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, specializing in the design and production of amorphous metal parts. Founded in 2017, Vulkam focuses on creating biocompatible amorphous metal alloys primarily composed of zirconium, copper, hafnium, nickel, and titanium. The company's innovative products serve various industries, including aerospace, automotive, biomedical, and microcomponents. Vulkam's micromechanical parts are notable for their small size and exceptional strength, offering performance comparable to established industry standards. By leveraging advanced materials science, Vulkam aims to set new benchmarks in metallurgy and metal processing, catering to the growing demand for high-performance, functional components in diverse applications.
Adionics is a technology company based in Paris, France, specializing in desalination and saline water valorization. Founded in 2012, the company develops innovative solutions to selectively remove salts from brine, seawater, and other salty waters. Its flagship technology, AquaOmnes, effectively separates salt from water, while Flionex is a selective extractant composition designed for the extraction of lithium salts. Adionics focuses on providing its services to various sectors, including municipal water, power, oil and gas, and chemicals. The company is also engaged in research and development to enhance its processes, particularly in the area of lithium recycling from batteries, aiming to deliver efficient, economical solutions with minimal environmental impact.
Aledia
Venture Round in 2023
Aledia SA, established in 2011, specializes in the development and manufacturing of light-emitting diodes (LEDs). The company's proprietary technology involves a 3D architecture using gallium-nitride-on-silicon microwires, enabling cost-effective production of LED chips at 25% the cost of traditional planar LED chips. Aledia's products cater to general lighting, automotive, and display applications, with a focus on mobile displays and microdisplays for AR/VR devices. Headquartered in Grenoble, France, the company has subsidiaries in Malacca, Malaysia, and Palo Alto, California.
Remedee Labs
Series A in 2022
Remedee Labs SAS is a French company founded in 2016, dedicated to developing innovative solutions for chronic pain management. The company has created the Microelectronic Endorphin Trigger (MEET), a personal endorphin stimulator that facilitates on-demand stimulation of the body’s natural endorphins to alleviate pain. Drawing on a decade of pre-clinical and clinical research, Remedee Labs aims to improve the quality of life for the 1.5 billion people worldwide suffering from chronic pain, particularly focusing on conditions such as fibromyalgia. By collaborating with medical practitioners, the company offers a patient-centered digital service platform that enhances the accessibility and effectiveness of endorphin-stimulation therapy for personal healthcare. As it continues to evolve, Remedee Labs plans to expand its platform to address additional chronic pain conditions, positioning itself as a leader in neuromodulation technology for pain management.
Prophesee
Series C in 2022
Prophesee SA, founded in 2014 and based in Paris, France, specializes in developing advanced machine vision sensors and systems. Renowned for its neuromorphic vision technology, the company has created a unique visual processing platform that mimics human vision by detecting events rather than capturing sequences of images. This innovative Metavision® approach enables significant advancements in speed, dynamic range, data efficiency, and power consumption, making it suitable for a variety of applications including autonomous driving, mobile devices, industrial automation, and security systems. Prophesee serves a diverse clientele across multiple sectors such as biomedical, gaming, robotics, and aerospace. The company boasts a team of over 100 engineers and holds more than 50 international patents, positioning itself as a leader in next-generation vision technologies.
Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.
Diabeloop
Series C in 2022
Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.
Micropep Technologies is an agricultural biotechnology company founded in 2016 and based in Toulouse, France. The company specializes in the development of non-GMO bioherbicides and biostimulants utilizing its innovative miPEP technology, which harnesses naturally-occurring micro-peptides to regulate gene expression and enhance plant growth. Micropep focuses on four key development programs: germination, flowering, growth, and weed control, aiming to improve agricultural yields while maintaining the integrity of plant DNA. By leveraging the potential of these biomimetic peptides, Micropep seeks to provide effective solutions for managing plant genetics and enhancing resistance to diseases, thereby supporting sustainable farming practices.
Adionics
Seed Round in 2021
Adionics is a technology company based in Paris, France, specializing in desalination and saline water valorization. Founded in 2012, the company develops innovative solutions to selectively remove salts from brine, seawater, and other salty waters. Its flagship technology, AquaOmnes, effectively separates salt from water, while Flionex is a selective extractant composition designed for the extraction of lithium salts. Adionics focuses on providing its services to various sectors, including municipal water, power, oil and gas, and chemicals. The company is also engaged in research and development to enhance its processes, particularly in the area of lithium recycling from batteries, aiming to deliver efficient, economical solutions with minimal environmental impact.
PowerUp
Venture Round in 2020
PowerUp Technology, founded in 2017 and based in Aulnay-Sous-Bois, France, specializes in designing and marketing advanced battery management and optimization solutions. The company focuses on providing smart chargers that optimize charging conditions based on battery temperature, charge status, and degradation levels. PowerUp's innovative solutions offer real-time monitoring of battery health, enabling effective management of battery fleets through a user-friendly web application. Their offerings are applicable across various sectors, including railway systems, specialized equipment, backup batteries, portable tools, personal vehicles, and consumer electronics. By leveraging its technology, PowerUp aims to reduce the economic and ecological costs associated with battery usage, facilitating predictive maintenance and extending the service life of batteries.
Ynsect is a biotechnology company based in Evry, France, that specializes in the production and processing of insects for sustainable animal feed and non-food applications. Founded in 2011, Ynsect operates insect vertical farms that convert insects into high-quality nutrition products, including proteins and lipids for livestock and pet diets. The company employs innovative bioconversion techniques to utilize organic resources, producing not only animal feed but also organic fertilizers, bioenergy, and other valuable materials. Ynsect's expertise in large-scale insect farming and automation has positioned it as a leading provider in the agro-food and environmental biotech sectors, making it a favored partner for agricultural professionals, research institutions, and investors.
Microoled
Series A in 2020
Microoled, established in 2007, specializes in the production of Active Matrix Organic Light Emitting Diode (AMOLED) displays and optical modules from its headquarters and manufacturing facility in Grenoble, France. The company caters to diverse industries including consumer electronics, medical professionals, and security sectors by offering a broad range of products for applications like video glasses, head-mounted sports devices, camera viewfinders, and professional equipment worldwide. Microoled's focus lies in resolving customer-level issues through innovative solutions that anticipate market needs.
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, specializing in the design and production of amorphous metal parts. Founded in 2017, Vulkam focuses on creating biocompatible amorphous metal alloys primarily composed of zirconium, copper, hafnium, nickel, and titanium. The company's innovative products serve various industries, including aerospace, automotive, biomedical, and microcomponents. Vulkam's micromechanical parts are notable for their small size and exceptional strength, offering performance comparable to established industry standards. By leveraging advanced materials science, Vulkam aims to set new benchmarks in metallurgy and metal processing, catering to the growing demand for high-performance, functional components in diverse applications.
Diabeloop
Series B in 2019
Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.
Remedee Labs
Series A in 2019
Remedee Labs SAS is a French company founded in 2016, dedicated to developing innovative solutions for chronic pain management. The company has created the Microelectronic Endorphin Trigger (MEET), a personal endorphin stimulator that facilitates on-demand stimulation of the body’s natural endorphins to alleviate pain. Drawing on a decade of pre-clinical and clinical research, Remedee Labs aims to improve the quality of life for the 1.5 billion people worldwide suffering from chronic pain, particularly focusing on conditions such as fibromyalgia. By collaborating with medical practitioners, the company offers a patient-centered digital service platform that enhances the accessibility and effectiveness of endorphin-stimulation therapy for personal healthcare. As it continues to evolve, Remedee Labs plans to expand its platform to address additional chronic pain conditions, positioning itself as a leader in neuromodulation technology for pain management.
CAILabs SAS is a French deep tech company headquartered in Rennes, specializing in the design, development, and production of photonic solutions aimed at optimizing light utilization in various applications. Established in 2013, CAILabs focuses on innovative optical components, particularly through its patented Multi-Plane Light Conversion (MPLC) technology. The company provides a range of products, including mode multiplexers, light converters, and laser beam shaping solutions tailored for the telecommunications and industrial laser sectors. Its offerings are designed to enhance the performance of fiber optic networks and laser material processing, addressing critical challenges such as atmospheric turbulence and the need for efficient signal multiplexing. CAILabs aims to leverage its expertise and technological innovations to create reliable and cost-effective solutions for clients in the photonics industry.
Keranova
Venture Round in 2019
Keranova S.A., founded in 2015 and based in Saint Etienne, France, with an additional office in Vénissieux, specializes in the design and development of innovative surgical equipment for ophthalmologic procedures, specifically targeting the anterior segment of the eye. The company focuses on creating advanced surgical instruments that utilize a unique patented technology to enhance the efficiency and accuracy of ophthalmic surgeries. By introducing automation into these procedures, Keranova aims to reduce the reliance on manual techniques, offering equipment equipped with vision systems, intelligent software, and precise robotic movements. This approach represents a significant advancement in ophthalmic surgery, allowing for more reproducible outcomes and improved patient care.
NH TherAguix
Series A in 2019
NH TherAguix SAS is a clinical-stage pharmaceutical company based in Villeurbanne, France, focused on the development of nanomedicines for cancer treatment. The company specializes in creating innovative therapeutics that enhance radiotherapy for solid tumors. Its lead product, AGuIX, is a theranostic nanoparticle designed to improve the localization of tumors and optimize radiation therapy outcomes. By facilitating intravenous administration, AGuIX enables healthcare professionals to determine the best timing for irradiation, targets tumor tissues more effectively, and minimizes adverse effects on healthy tissues by reducing radiation doses. Founded in 2015, NH TherAguix is dedicated to advancing cancer treatment through its pioneering approach to combining imaging and radiotherapy.
Diota is a company based in Massy, France, specializing in augmented reality (AR) software solutions tailored for industrial applications. Founded in 2009, the company focuses on integrating digital data with human operators to enhance the efficiency of complex industrial processes. Its flagship product, DiotaPlayer, facilitates the use of AR across various industrial sectors, including manufacturing, aerospace, automotive, and oil and gas. The software allows users to browse, interact with, check, report, and track information seamlessly within existing hardware and software environments. Diota’s solutions are compatible with multiple devices, such as tablets and head-mounted displays, making them versatile for different operational needs. Additionally, the company offers consulting, technical support, and training services to optimize the implementation of its technologies. Diota's client base includes major industry players such as Safran Group, Dassault Aviation, and Renault, positioning it as a key contributor to the digital transformation of the industrial landscape in Europe.
Prophesee
Series B in 2018
Prophesee SA, founded in 2014 and based in Paris, France, specializes in developing advanced machine vision sensors and systems. Renowned for its neuromorphic vision technology, the company has created a unique visual processing platform that mimics human vision by detecting events rather than capturing sequences of images. This innovative Metavision® approach enables significant advancements in speed, dynamic range, data efficiency, and power consumption, making it suitable for a variety of applications including autonomous driving, mobile devices, industrial automation, and security systems. Prophesee serves a diverse clientele across multiple sectors such as biomedical, gaming, robotics, and aerospace. The company boasts a team of over 100 engineers and holds more than 50 international patents, positioning itself as a leader in next-generation vision technologies.
Aledia SA, established in 2011, specializes in the development and manufacturing of light-emitting diodes (LEDs). The company's proprietary technology involves a 3D architecture using gallium-nitride-on-silicon microwires, enabling cost-effective production of LED chips at 25% the cost of traditional planar LED chips. Aledia's products cater to general lighting, automotive, and display applications, with a focus on mobile displays and microdisplays for AR/VR devices. Headquartered in Grenoble, France, the company has subsidiaries in Malacca, Malaysia, and Palo Alto, California.